Latest

Learn how antibiotic-resistant UTI testing identifies ESBL, CRE, resistance genes, and antibiotic susceptibility, and how culture results guide treatment and follow-up.

Antibiotic-Resistant UTI Test: ESBL, CRE, Resistance Markers, and Culture Meaning

Learn what asymptomatic bacteriuria means, how a positive urine culture without UTI symptoms is interpreted, and when screening, treatment, or follow-up matters.

Asymptomatic Bacteriuria Test: Positive Culture Without Symptoms and When It Matters

Learn how bacteria in urine are interpreted using urinalysis, culture, colony count, symptoms, and sample quality, including when contamination or follow-up testing matters.

Bacteria in Urine Test: UTI, Contamination, Colony Count, and Culture Follow-Up

Learn how a catheter urine culture helps diagnose catheter-associated UTI, how samples are collected, and what colony counts, pyuria, resistance, and positive results mean.

Catheter Urine Culture Test: Catheter-Associated UTI and Culture Meaning

Learn how a chlamydia and gonorrhea urine NAAT works, how to collect first-catch urine, what positive or negative results mean, and when follow-up testing is needed.

Chlamydia and Gonorrhea Urine NAAT Test: STI Screening, Positive Result, and Meaning

Learn how to collect a clean-catch urine culture, reduce contamination, handle the sample correctly, and understand mixed flora, colony counts, repeat testing, and accurate results.

Clean-Catch Urine Culture Test: Sample Collection, Contamination, and Accurate Results

Diagnostics

Home Diagnostics Page 33

Learn what a KIT mutation test means in GIST, melanoma, and mast cell disease, including exon-specific results, KIT D816V, treatment relevance, CD117 differences, and testing limitations.

KIT Mutation Test: GIST, Melanoma, Mast Cell Disease, Mutation Status, and...

Understand KRAS mutation test results in colon, lung, and pancreatic cancer, including G12C, G12D, treatment resistance, targeted therapy, negative results, and testing limits.

KRAS Mutation Test: Colon, Lung, Pancreatic Cancer, Mutation Status, and Result...

Understand MDM2 amplification testing for liposarcoma, including FISH ratios, copy number gain, polysomy, positive and negative results, diagnostic pitfalls, and next steps.

MDM2 Amplification Test: Liposarcoma, Copy Number Gain, Tumor Diagnosis, and FISH...

Understand MET amplification test results in lung and gastric cancer, including FISH ratios, NGS copy number, polysomy, high-level amplification, resistance, and treatment implications.

MET Amplification Test: Lung Cancer, Gastric Cancer, Copy Number Gain, and...

Understand MSI test results for Lynch syndrome and cancer care, including MSI-H, MSS, mismatch repair deficiency, immunotherapy relevance, hereditary follow-up, discordant results, and next steps.

Microsatellite Instability (MSI) Test: Lynch Syndrome, Mismatch Repair, Cancer Risk, and...

Understand MMR gene testing for MLH1, MSH2, MSH6, PMS2, EPCAM, and Lynch syndrome, including IHC patterns, MSI, germline results, cancer risk, and next steps.

Mismatch Repair (MMR) Gene Test: MLH1, MSH2, MSH6, PMS2, and Lynch...

Understand MLH1 mutation testing for Lynch syndrome and colon cancer, including MLH1/PMS2 loss, promoter methylation, BRAF triage, germline variants, cancer risk, and result meaning.

MLH1 Mutation Test: Lynch Syndrome, Colon Cancer, Mismatch Repair, and Variant...

Understand MPL mutation test results in thrombocytosis and myeloproliferative neoplasms, including W515 variants, ET versus myelofibrosis, negative results, VAF, prognosis, and next steps.

MPL Mutation Test: Myeloproliferative Neoplasm, Platelets, Thrombocytosis, and Result Meaning

Understand MSH2 mutation testing for Lynch syndrome, including MSH2/MSH6 loss, EPCAM deletions, germline results, colorectal and urinary-tract cancer risk, MSI, and next steps.

MSH2 Mutation Test: Lynch Syndrome, Colon Cancer, Mismatch Repair, and Variant...

Understand MSH6 mutation testing for Lynch syndrome, including isolated MSH6 loss, MSI findings, germline variants, colorectal and endometrial cancer risk, surveillance, and next steps.

MSH6 Mutation Test: Lynch Syndrome, Colon Cancer, Mismatch Repair, and Variant...

Understand MUTYH mutation testing, including biallelic versus monoallelic results, polyposis and colon cancer risk, variant meaning, surveillance, and family testing.

MUTYH Mutation Test: Colon Cancer, Polyposis, Variant Meaning, and Hereditary Risk

Learn what a MYC rearrangement FISH test detects, how positive and negative results are interpreted, and what MYC means in Burkitt, high-grade B-cell lymphoma, and leukemia.

MYC Rearrangement Test: Lymphoma, Leukemia, High-Grade Disease, and FISH Result

Understand MYD88 L265P testing in Waldenström macroglobulinemia and lymphoma, including positive and negative results, test methods, CXCR4 context, and treatment meaning.

MYD88 Mutation Test: Waldenstrom Macroglobulinemia, Lymphoma, L265P Variant, and Meaning

Understand NPM1 mutation testing in AML, including prognosis, FLT3 risk groups, molecular MRD monitoring, positive and negative results, and what changing NPM1 levels mean.

NPM1 Mutation Test: AML Prognosis, MRD Monitoring, Mutation Status, and Meaning

Understand NRAS mutation testing in melanoma and colorectal cancer, including positive and negative results, RAS treatment implications, methods, and follow-up.

NRAS Mutation Test: Melanoma, Colon Cancer, Mutation Status, and Result Meaning

Learn what an NTRK fusion test means, how NTRK1/2/3 fusions are detected, why they are tumor-agnostic markers, and how positive results guide TRK therapy.

NTRK Fusion Test: Gene Fusion, Tumor-Agnostic Marker, Positive Result, and Meaning

1...323334...137 Page 33 of 137